Persistent Corneal Epithelial Defect
11
3
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
18.2%
2 terminated out of 11 trials
66.7%
-19.8% vs benchmark
18%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
Autologous Platelet Lysate in Corneal Epithelial Defects
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect